IRIS
OSELLA, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.179
EU - Europa 11.210
AS - Asia 5.727
SA - Sud America 922
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 176
OC - Oceania 5
Totale 31.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.865
RU - Federazione Russa 2.633
IE - Irlanda 2.354
SG - Singapore 1.753
SE - Svezia 1.690
CN - Cina 1.573
DE - Germania 1.479
UA - Ucraina 1.109
HK - Hong Kong 906
VN - Vietnam 739
BR - Brasile 700
FI - Finlandia 657
IT - Italia 439
FR - Francia 379
GB - Regno Unito 250
IN - India 213
CA - Canada 175
KR - Corea 113
AR - Argentina 87
BD - Bangladesh 81
MX - Messico 62
BJ - Benin 52
ID - Indonesia 50
PL - Polonia 46
IR - Iran 42
JP - Giappone 39
TR - Turchia 39
ZA - Sudafrica 39
EC - Ecuador 35
BE - Belgio 34
ES - Italia 29
CO - Colombia 27
IQ - Iraq 27
EU - Europa 23
UZ - Uzbekistan 23
NL - Olanda 22
AT - Austria 19
CL - Cile 18
PY - Paraguay 18
MA - Marocco 17
PK - Pakistan 16
CR - Costa Rica 15
TH - Thailandia 15
LT - Lituania 14
SA - Arabia Saudita 14
VE - Venezuela 13
EG - Egitto 12
JM - Giamaica 12
PH - Filippine 12
RO - Romania 12
KE - Kenya 11
TN - Tunisia 11
DZ - Algeria 9
UY - Uruguay 9
BO - Bolivia 8
NP - Nepal 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
HN - Honduras 7
JO - Giordania 7
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
NI - Nicaragua 6
PR - Porto Rico 6
SV - El Salvador 6
TW - Taiwan 6
AU - Australia 5
AZ - Azerbaigian 5
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
PA - Panama 4
PE - Perù 4
PS - Palestinian Territory 4
CI - Costa d'Avorio 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
LB - Libano 3
OM - Oman 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 31.218
Salva come PNG Salva come JPEG
Città #
Dublin 2.348
Jacksonville 1.889
San Jose 1.062
Dearborn 985
Hong Kong 898
Chandler 805
Singapore 759
Ashburn 668
Council Bluffs 660
Wilmington 577
Beijing 510
Moscow 402
Lawrence 319
Princeton 319
Lauterbourg 289
New York 257
Ann Arbor 256
Los Angeles 254
San Mateo 253
Ho Chi Minh City 244
Andover 202
Buffalo 163
Hanoi 155
Columbus 144
Piemonte 133
Seoul 108
Houston 102
Munich 102
Santa Clara 102
Boardman 101
Philadelphia 101
Woodbridge 93
Düsseldorf 89
Dallas 82
São Paulo 79
Toronto 76
Orem 74
Redondo Beach 59
Atlanta 58
Bremen 58
Guangzhou 53
Cotonou 52
Chicago 49
Grafing 49
Hefei 47
Nanjing 47
Helsinki 46
Phoenix 45
Norwalk 42
Frankfurt am Main 40
Kunming 36
Montreal 36
Denver 35
Tokyo 35
Tianjin 34
Chennai 33
Da Nang 33
Brussels 32
Warsaw 31
Brooklyn 29
Monmouth Junction 28
Leawood 27
Stockholm 27
Shanghai 26
Rio de Janeiro 25
Hangzhou 24
Mexico City 24
Haiphong 23
London 23
North Bergen 23
San Francisco 23
Biên Hòa 21
Boston 21
Fairfield 21
Tashkent 21
Manchester 20
Novara 20
Mumbai 19
Poplar 19
Seattle 19
Shenzhen 19
Zanjan 19
Belo Horizonte 18
Nuremberg 17
Ankara 16
Cave Creek 16
Jinan 16
Johannesburg 16
Turku 16
Hải Dương 15
Hebei 14
Milan 14
Rome 14
Ardabil 13
Augusta 13
Bexley 13
Charlotte 13
Shenyang 13
Amsterdam 12
Curitiba 12
Totale 17.392
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 182
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 171
A view on multi-action Pt(IV) antitumor prodrugs 167
195Pt NMR chemical shift: a chemometric approach 160
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 159
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 159
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 155
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 153
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 152
Antioxidant Composition of a Selection of Italian Red Wines and Their Corresponding Free-Radical Scavenging Ability 152
Transition metal carbonyl clusters in biology: A futile or niche research area? 152
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 152
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 151
A different way for the oxidation of the Pt(II) complexes 149
13C Solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12] 149
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 148
Haemolymph from Mytilus galloprovincialis: Response to copper and temperature challenges studied by 1H-NMR metabonomics 148
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 148
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 147
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 145
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 145
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 145
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 145
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 143
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 142
1H-NMR SPIN-LATTICE RELAXATION STUDIES OF HYDRIDOMETAL CLUSTERS OF RUTHENIUM AND OSMIUM 141
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 140
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 140
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 140
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 139
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 139
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 139
Different strategies to exploit Pt(IV) complexes as pro-drugs 138
ACTIVATION OF THE M-CO BOND IN TRANSITION-METAL COMPLEXES. FE2(CO)6(SME)2 AND PHOSPHINE-SUBSTITUTED DERIVATIVES AS GOOD CATALYSTS IN METAL-CARBONYL SUBSTITUTION-REACTIONS 134
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 133
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 133
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process. 132
Activation of alkynes by transition metals 130
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 130
Effect of arbuscular mycorrhizal and bacterial inocula on nitrate concentration in mesocosms simulating a wastewater treatment system relying on phytodepuration 130
199Hg NMR of mercury-bridged transition metal clusters 130
17O NMR spectroscopy of transition metal carbonyls 129
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 129
An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2 126
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 126
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 126
Authentication and traceability study of Hazelnuts from piedmont, italy 125
Wine Traceability with Rare Earth Elements 125
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 124
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 124
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 123
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 122
A MECHANISTIC STUDY OF THE REACTION OF H2OS3(CO)10 WITH TERMINAL ALKYNES 121
A novel bonding scheme of an allene system in a transition metal cluster complex. Molecular structure of μ3-η-(1-methyl-3-ethyl-3-allenyl)-μ-hydrido-triangulo- tris(tricarbonylruthenium)(3Ru-Ru) 121
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 121
Pt-195 NMR spectroscopy: A chemometric approach 121
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 120
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 120
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 119
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 119
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 118
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 118
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process 117
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 117
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 117
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 116
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 116
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 115
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 115
The effects of sulphur dioxide on wine metabolites: New insights from 1H NMR spectroscopy based in-situ screening, detection, identification and quantification 115
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 114
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 114
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 114
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 113
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 113
A 13C NMR investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium 113
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 112
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 112
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 112
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 112
13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants 112
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 110
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 110
Solution structure and dynamics of H2Ru4(CO)13 109
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 109
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 109
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 109
13C-13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt 109
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 109
Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls 108
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 108
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 108
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 107
Pt(IV) complexes as anticancer prodrugs 107
Wine evolution during bottle aging, studied by 1H NMR spectroscopy and multivariate statistical analysis 107
THE ALKYNE CLUSTER INTERACTION - STRUCTURAL, THEORETICAL, AND SPECTROSCOPIC STUDY ON THE PARALLEL μ3-η2 BONDING MODE IN TRINUCLEAR CARBONYL CLUSTERS OF RUTHENIUM AND OSMIUM 106
μ3-S bonding mode in H2M3(CO)9S clusters of Ru and Os. An UV-PES and theoretical study 106
THERMAL AND PHOTOCHEMICAL BEHAVIOR OF ORGANOTETRARUTHENIUM CLUSTERS: SOLUTION STRUCTURES AND DYNAMICS OF PHOSPHINE-SUBSTITUTED DERIVATIVES 106
High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12 105
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 104
Totale 12.779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.674
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.753 0 0 0 363 117 1 257 43 139 35 347 451
2022/20235.085 338 133 303 231 418 590 81 277 2.426 39 161 88
2023/20241.162 120 103 102 25 269 1 244 10 4 6 126 152
2024/20252.605 24 44 105 101 106 186 244 187 809 343 85 371
2025/202610.045 411 379 806 1.414 781 790 1.539 1.755 794 691 425 260
2026/20272.296 410 737 516 633 0 0 0 0 0 0 0 0
Totale 31.469